TIToshihiro Inoue

Toshihiro Inoue

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Toshihiro Inoue has a total of 273 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Protocol for the SACLA trial: Efficacy and safety of subretinal monteplase for submacular hemorrhage in a phase II single-arm multicenter decentralized clinical trial

    by Noriko Yoshida, Yuko Kobayakawa, Kouta Funakoshi, Sakiko Kimura, Kazuhisa Hosoya, Yuya Shinkawa, Takuma Furukawa, Tsubasa Mitsutake, Toshimi Hoshiko, Ayako Takamori, et al.

    Submacular hemorrhage (SMH), which may arise from age-related macular degeneration, retinal arterial macroaneurysm, and other causes, can result in severe vision loss and central visual field impairment. Although tissue plasminogen activator (tPA) is used off-label to treat SMH in many countries, no formulation has been approved for this indication. Because early intervention is critical when tPA is used for SMH, limited access to centers that can provide this treatment may delay care and reduce treatment opportunities. Decentralized clinical trials (DCTs) reduce or eliminate the need for participants to travel to trial sites. We therefore designed the investigator-initiated SACLA trial to evaluate subretinal tPA for SMH. The DCT framework is intended to reduce logistical barriers related to the disease severity and rarity. The SACLA trial is a phase II multicenter, open-label, single-arm surgical study with a pre-post comparison design (jRCT2071250003). Twenty eligible participants will undergo pars plana vitrectomy followed by subretinal injection of 0.1 mL (8,000 IU) of tPA. Participants will remain hospitalized at the trial site until the primary outcome, change in central foveal thickness (CFT) from baseline at Week 1, is assessed. Thereafter, follow-up visits will be conducted at either the trial site or partner sites within the DCT framework. Secondary efficacy outcomes include change in CFT from baseline, presence of a foveal hemorrhage measuring at least 1 disc diameter, best-corrected visual acuity (BCVA), and change in BCVA from baseline at Weeks 4 and 12. Adverse events will be collected throughout the 12-week observation period to assess safety. The protocol and related study documents were reviewed and approved by the Saga University Hospital Institutional Review Board. This study is designed to generate prospective evidence on the feasibility, short-term anatomical response, and safety of subretinal tPA for SMH.

  • Open Access

    Large-scale proteomic analysis of aqueous humor from patients with primary open angle and exfoliation glaucoma

    by Naofumi Funagura, Tomokazu Fujimoto, Eri Takahashi, Sachi Kojima, Yuji Takihara, Natsumi Murata, Miyuki Inoue-Mochita, Toshihiro Inoue

    A large-scale proteomic approach was used to evaluate the protein profiles of aqueous humor obtained from patients with primary open angle glaucoma (POAG) and exfoliation glaucoma (EXG). The study population consisted of 15 POAG and 15 EXG patients, and 10 patients with no previous ophthalmic treatment as controls. Aqueous humor was collected at the beginning of surgery. Proteins were analyzed using the SOMAscan platform. Among the 7,335 human proteins identified in the aqueous humor of POAG and EXG patients, 215 and 330, respectively, were upregulated, as compared to controls. A pathway-enrichment analysis of the proteins upregulated in both POAG and EXG revealed enrichment of those involved in trabecular meshwork remodeling. Among the 43 and 23 proteins downregulated in POAG and EXG, respectively, was GSTP1, whose null genotype has been shown to increase the risk of POAG in Asians. SOMAscan analysis of the aqueous humor proteins of POAG and EXG patients revealed enrichment of pathways related to the onset and progression of glaucoma, as well as novel disease-associated proteins. These results demonstrate the advantages of SOMAscan, including its high detection sensitivity and accuracy even in analyses of a small number of samples.


  • Open Access

    Silencing of ocular transthyretin, a gene responsible for hereditary transthyretin amyloidosis, by intravitreal injection of an siRNA conjugate into rabbit eyes

    by Takahiro Watanabe, Yuji Takihara, Hirofumi Jono, Tomokazu Fujimoto, Masayoshi Tasaki, Aito Isoguchi, Yui Urahashi, Takefumi Shimoda, Eri Takahashi, Yukio Ando, et al.


  • Trabeculotomy Using the Kahook Dual Blade for Exfoliation Glaucoma and Primary Open Angle Glaucoma: Comparison of Outcomes According to Incision Range

    by Anna Irie, Kei-Ichi Nakashima, Toshihiro Inoue, Sachi Kojima, Yuji Takihara, Eri Takahashi

    Précis: Large amount of trabeculotomy with Kahook Dual Blade (KDB) confers better intraocular pressure (IOP) lowering. Purpose: We compared the postoperative outcomes of trabeculotomy using the KDB in patients with exfoliation glaucoma (EXG) and primary open angle glaucoma between the 120-degree incision and the 210- to 240-degree incision groups. Patients and Methods: We retrospectively analyzed the postoperative outcomes of trabeculotomy performed using the KDB in 101 eyes with EXG and primary open angle glaucoma, who received 120- and 210- to 240-degree incisions at Kumamoto University Hospital between April 25, 2018, and August 11, 2021. Kaplan-Meyer survival curves were used to assess the outcomes. Surgical failure was defined as IOP ≥21 mm Hg (criterion A) and ≥19 mm Hg (criterion B), or an IOP ≤4 mm Hg in either criterion and the need for additional glaucoma surgery. Results: In total, 64 and 37 eyes were included in the 120 and 210- to 240-degree groups, respectively. The 210- to 240-degree group had a higher 1-year success rate compared with the 120-degree group, both when considering all eyes and when considering only those with EXG (P<0.05). Conclusions: In trabeculotomy with KDB, a 210- to 240-degree incision was more effective than a 120-degree incision in lowering IOP in EXG cases.


  • Open Access

    Tissue Reactivity to, and Stability of, Glaucoma Drainage Device Materials Placed Under Rabbit Conjunctiva

    by Kenichi Nakamura, Tomokazu Fujimoto, Miho Okada, Kentaro Maki, Atsushi Shimazaki, Masatomo Kato, Toshihiro Inoue

    Purpose: To evaluate tissue reactivity to, and the stability of, glaucoma drainage device materials placed under rabbit conjunctiva in vivo. Methods: Disks (diameter, 3 mm; thickness, ∼0.3 mm) fabricated from poly(styrene-block-isobutylene-block-styrene) (SIBS), silicone, stainless-steel, or glutaraldehyde cross-linked collagen (GACLC) were inserted under rabbit conjunctiva. Conjunctival and scleral sections obtained at 4, 8, and 12 weeks after surgery were immunostained for α-smooth muscle actin (SMA). The ratio of the maximum thickness of the α-SMA–positive conjunctiva to the scleral thickness (α-SMA/S ratio) was calculated. The in vivo stability of the drainage devices at 12 weeks after insertion was evaluated. Results: The mean α-SMA/S ratios of the SIBS and silicone groups were lower than that of the stainless-steel group at 4 weeks after surgery (P < 0.05), and that of the SIBS group was lower than that of the GACLC group (P < 0.05). The ratios at 8 weeks after surgery were lower in the SIBS and silicone groups than in the GACLC group (P < 0.01). The ratios at 12 weeks after surgery were lower in the SIBS and silicone groups than in the GACLC group (P < 0.05). The surface areas of GACLC disks explanted from conjunctivae were significantly lower than that of intact disks (P < 0.01). Conclusions: SIBS and silicon were highly biostable and exhibited less tissue reactivity than GACLC in vivo. Translational Relevance: Comparisons of materials using animal models can predict the clinical stability and safety of such materials in humans.


  • Open Access

    社会経済活動によって変容するエネルギー需要

    by Toshihiro Inoue

    エネルギー需要は社会経済活動に密接に関係しており,新型コロナウイルス感染症(COVID-19)対策としての外出・移動や施設利用への制限がもたらした影響を強く反映している。本稿では,2020年以降の世界と日本のエネルギー需給の変化について概説する。また,日本のエネルギー需要データと,経済指標,人流データを用いた分析結果を紹介し,社会活動の変化がエネルギー需給構造に与える影響について解説する。

  • Open Access

    Elevated Cytokine Levels in Aqueous Humor Are Associated with Peripheral Anterior Synechiae after Penetrating Keratoplasty

    by Yuki Kusano, Takefumi Yamaguchi, Sota Nishisako, Takehiro Matsumura, Masaki Fukui, Kazunari Higa, Toshihiro Inoue, Jun Shimazaki

    Peripheral anterior synechiae (PAS) after corneal transplantation leads to refractory glaucoma and permanent loss of vision. However, the exact mechanism remains elusive. This study aimed to evaluate the association between cytokine levels in the aqueous humor (AqH) and the progression of PAS after penetrating keratoplasty (PKP). We measured 20 cytokine levels in AqH and assessed the correlation with PAS progression after PKP in 85 consecutive patients who underwent PKP. We also evaluated age-dependent alterations in PAS and cytokine levels in DBA2J mice. PAS developed in 38 (44.7%) of 85 eyes after PKP. The incidence of intraocular pressure increase after PKP was significantly greater in eyes with PAS (26.3%) than in those without PAS (2%, p = 0.0009). The PAS area at 12 months after PKP was significantly positively correlated with the preoperative levels of interleukin (IL)-6, interferon (IFN)-γ and monocyte chemotactic protein (MCP)-1 (p ≤ 0.049). In the DBA2J mice, an experimental glaucoma model that developed PAS at 50 weeks, the AqH levels of IL-2, IL-6, IL-10, IFN-γ, tumor necrosis factor-α, MCP-1 and granulocyte-macrophage colony-stimulating factor (GM-CSF) significantly increased at 50 weeks compared to 8 weeks (p ≤ 0.021). In conclusion, inflammatory alterations in the AqH microenvironment, such as high preoperative specific cytokine levels, can lead to PAS formation and glaucoma.


  • Open Access

    Suberoylanilide hydroxamic acid (SAHA) inhibits transforming growth factor-beta 2-induced increases in aqueous humor outflow resistance

    by Tomokazu Fujimoto, Miyuki Inoue-Mochita, Satoshi Iraha, Hidenobu Tanihara, Toshihiro Inoue


  • Potential roles of the IL-6 family in conjunctival fibrosis

    by Fumika Watanabe-Kitamura, Akiko Ogawa, Tomokazu Fujimoto, Satoshi Iraha, Miyuki Inoue-Mochita, Takahiro Watanabe, Eri Takahashi, Hidenobu Tanihara, Toshihiro Inoue